ACAD
38.16
+0.19
+0.49%
AEMD
0.19
0.00
0.00%
APRI
2.32
+0.12
+5.46%
ARNA
4.25
-0.26
-5.76%
ATEC
1.54
+0.09
+6.21%
CFN
60.16
+0.08
+0.13%
CNAT
6.43
+0.07
+1.10%
CRXM
0.21
0.00
0.00%
CYTX
1.08
-0.04
-3.57%
DXCM
60.18
-0.56
-0.92%
GNMK
12.97
+0.26
+2.05%
HALO
15.15
+0.08
+0.53%
ILMN
194.05
-1.41
-0.72%
INNV
0.15
0.00
0.00%
INO
7.22
+0.14
+2.05%
ISCO
0.06
0.00
-1.83%
ISIS
66.46
-2.1
-3.06%
LGND
58.47
+3.4
+6.16%
LPTN
2.93
0.00
0.00%
MBVX
0.94
0.00
0.00%
MEIP
5.82
-0.07
-1.19%
MNOV
3.59
+0.05
+1.41%
MRTX
23.74
-0.03
-0.13%
MSTX
0.54
+0.02
+3.40%
NBIX
40.37
+1.32
+3.38%
NUVA
45.84
+0.09
+0.20%
ONCS
0.37
0.00
-1.31%
ONVO
5.75
-0.17
-2.87%
OREX
5.66
+0.02
+0.35%
OTIC
37.38
+0.3
+0.81%
QDEL
26.17
+0.49
+1.91%
RCPT
125.63
-1.01
-0.80%
RGLS
18.41
-0.11
-0.59%
RMD
64.32
-0.05
-0.07%
SCIE
0.03
+0.00
+3.64%
SPHS
0.72
-0.08
-10.27%
SRNE
12.79
-0.13
-1.01%
TROV
5.71
+0.06
+1.06%
VICL
1.02
0.00
0.00%
VOLC
17.99
0.00
0.00%
ZGNX
1.69
+0.01
+0.60%
Home » Events

San Diego Biotech Discussion Group Biotalk

Submitted by on July 15, 2009 – 1:12 pm

“Tumor Targeting with Nanoparticles”
Marit Piacente, DVM – Head of Preclinical Development, Abraxis

July 29, 2009
5:30 – 8:00 pm
(Announcements begin at 6:30 pm)

AT SORRENTO SUMMIT

[[Click here for more information.]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


6 − = five